Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Anthony Elias

Concepts (665)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
111
2026
2411
5.850
Why?
Antineoplastic Combined Chemotherapy Protocols
97
2026
1996
3.800
Why?
Sarcoma
33
2025
209
3.600
Why?
Receptors, Estrogen
22
2021
405
2.190
Why?
Triple Negative Breast Neoplasms
14
2024
219
2.130
Why?
Hematopoietic Stem Cell Transplantation
36
2011
700
1.820
Why?
Carcinoma, Small Cell
19
2003
172
1.620
Why?
Soft Tissue Neoplasms
14
2022
133
1.480
Why?
Neoadjuvant Therapy
19
2026
474
1.450
Why?
Carcinoma, Ductal, Breast
7
2018
91
1.400
Why?
Antineoplastic Agents
31
2023
2218
1.160
Why?
Neoplasm Staging
38
2026
1486
1.120
Why?
Neoplasm Recurrence, Local
20
2022
1156
1.070
Why?
Receptors, Progesterone
13
2020
241
1.030
Why?
Combined Modality Therapy
52
2024
1269
0.950
Why?
Lung Neoplasms
38
2003
2674
0.950
Why?
Doxorubicin
24
2025
414
0.920
Why?
Biomarkers, Tumor
17
2022
1334
0.910
Why?
Antibodies, Monoclonal, Humanized
11
2026
992
0.910
Why?
Paclitaxel
14
2024
258
0.860
Why?
Bone Marrow Transplantation
27
1998
298
0.860
Why?
CTLA-4 Antigen
1
2025
105
0.850
Why?
Mastectomy
9
2018
188
0.820
Why?
Bone Neoplasms
7
2025
271
0.800
Why?
Antineoplastic Agents, Alkylating
5
2018
76
0.700
Why?
Female
171
2026
79080
0.700
Why?
Receptors, Androgen
7
2018
149
0.690
Why?
Humans
229
2026
145625
0.670
Why?
Disease-Free Survival
24
2023
777
0.660
Why?
Middle Aged
113
2026
36359
0.630
Why?
Maytansine
3
2021
18
0.620
Why?
Antineoplastic Agents, Hormonal
10
2018
196
0.620
Why?
Liposarcoma
4
2023
31
0.620
Why?
Neoplasm Metastasis
23
2024
693
0.560
Why?
Adult
115
2026
40821
0.560
Why?
Chemotherapy, Adjuvant
23
2023
429
0.550
Why?
Dioxoles
2
2015
9
0.530
Why?
Tetrahydroisoquinolines
2
2015
8
0.530
Why?
Cyclophosphamide
31
2024
275
0.530
Why?
Androgen Receptor Antagonists
6
2021
35
0.490
Why?
Ifosfamide
19
1998
39
0.490
Why?
Phenylthiohydantoin
5
2017
44
0.480
Why?
Dasatinib
1
2016
58
0.480
Why?
Aged
65
2025
26251
0.480
Why?
Trastuzumab
10
2024
119
0.460
Why?
Neoplasms, Hormone-Dependent
3
2012
33
0.460
Why?
Treatment Outcome
43
2024
11744
0.430
Why?
Drug Administration Schedule
24
2018
782
0.430
Why?
Carboplatin
21
2016
168
0.420
Why?
Estrogen Receptor alpha
5
2021
154
0.420
Why?
Granulocyte Colony-Stimulating Factor
11
2002
90
0.410
Why?
Carcinoma, Non-Small-Cell Lung
17
2001
1194
0.390
Why?
Clinical Trials as Topic
19
2018
1062
0.390
Why?
Estrogens
6
2018
364
0.380
Why?
Medical Oncology
6
2026
344
0.370
Why?
Dacarbazine
9
2018
98
0.370
Why?
Tamoxifen
9
2018
193
0.350
Why?
Survival Rate
19
2021
2078
0.340
Why?
Survival Analysis
23
2010
1372
0.330
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
973
0.330
Why?
Neoplasms
20
2009
2944
0.330
Why?
Prognosis
22
2021
4331
0.330
Why?
Venous Thromboembolism
3
2020
330
0.320
Why?
Programmed Cell Death 1 Receptor
2
2025
268
0.320
Why?
Pyrimidines
3
2020
530
0.320
Why?
Neoplasms, Second Primary
3
2022
103
0.320
Why?
Dose-Response Relationship, Drug
17
2017
2018
0.320
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2022
61
0.320
Why?
Antibodies, Monoclonal
9
2024
1511
0.310
Why?
Taxoids
7
2023
115
0.310
Why?
Remission Induction
16
2002
308
0.300
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
8
1999
158
0.300
Why?
Breast Neoplasms, Male
3
2018
29
0.300
Why?
Drug Resistance, Neoplasm
7
2017
889
0.280
Why?
Gene Expression Regulation, Neoplastic
11
2018
1429
0.280
Why?
Neoplastic Cells, Circulating
2
2020
81
0.280
Why?
Mesna
12
1998
15
0.270
Why?
Sarcoma, Ewing
3
2022
103
0.260
Why?
Leiomyosarcoma
2
2018
30
0.250
Why?
Cisplatin
14
2000
346
0.240
Why?
Sternum
1
2006
26
0.240
Why?
Immunoconjugates
3
2024
138
0.240
Why?
Immunohistochemistry
5
2016
1709
0.240
Why?
Tumor Microenvironment
4
2024
745
0.230
Why?
Mastectomy, Segmental
2
2009
107
0.230
Why?
Chondrosarcoma
1
2025
17
0.220
Why?
Carcinoma, Ductal
1
2005
10
0.220
Why?
Peripheral Blood Stem Cell Transplantation
2
2002
35
0.220
Why?
Melphalan
10
2002
43
0.220
Why?
Pyridines
2
2025
606
0.220
Why?
Isocitrate Dehydrogenase
1
2025
71
0.220
Why?
Transplantation, Autologous
19
2002
303
0.210
Why?
Cell Adhesion Molecules
2
2021
180
0.210
Why?
Carcinoma
2
2008
225
0.210
Why?
Lymph Nodes
1
2007
511
0.210
Why?
Male
66
2025
73014
0.210
Why?
Protein Kinase Inhibitors
4
2019
982
0.210
Why?
Risk Reduction Behavior
2
2016
219
0.210
Why?
Drug Evaluation
19
1998
78
0.200
Why?
Glycine
1
2025
184
0.200
Why?
Adjuvants, Immunologic
3
2022
243
0.200
Why?
Ribonuclease III
2
2016
44
0.200
Why?
Deoxycytidine
4
2020
219
0.200
Why?
Ovarian Neoplasms
3
2022
598
0.190
Why?
Survivors
3
2016
521
0.190
Why?
Thiotepa
13
2002
21
0.190
Why?
Alkylating Agents
3
2000
23
0.190
Why?
Hodgkin Disease
4
2016
173
0.190
Why?
DEAD-box RNA Helicases
2
2016
89
0.190
Why?
Triazoles
2
2022
190
0.190
Why?
Behavior Therapy
2
2016
290
0.180
Why?
Weight Loss
4
2016
857
0.180
Why?
Gene Expression Profiling
6
2017
1790
0.180
Why?
Disease Management
5
2020
649
0.180
Why?
Aged, 80 and over
14
2021
8351
0.180
Why?
Employment
1
2024
180
0.180
Why?
Mutation
4
2025
4082
0.180
Why?
Obesity
4
2018
3123
0.180
Why?
Hydrazines
1
2022
37
0.180
Why?
Overweight
3
2016
613
0.180
Why?
Salvage Therapy
6
2010
163
0.180
Why?
Carcinoma in Situ
2
2012
45
0.170
Why?
Circulating Tumor DNA
1
2022
50
0.170
Why?
Etoposide
10
2001
169
0.170
Why?
Tumor Cells, Cultured
9
2020
878
0.170
Why?
Hematologic Diseases
6
2008
66
0.170
Why?
Sarcoma, Synovial
1
2021
20
0.170
Why?
Liposarcoma, Myxoid
1
2021
10
0.170
Why?
Recombinant Fusion Proteins
1
2024
662
0.160
Why?
Emergency Medicine
1
2024
278
0.160
Why?
Referral and Consultation
1
2007
878
0.160
Why?
Endpoint Determination
1
2021
84
0.160
Why?
Aromatase Inhibitors
4
2021
81
0.160
Why?
Sentinel Lymph Node Biopsy
3
2017
117
0.160
Why?
Cell Separation
3
2017
300
0.160
Why?
Indazoles
1
2020
86
0.160
Why?
Cancer Care Facilities
1
2020
48
0.160
Why?
Leukocytes, Mononuclear
3
2020
585
0.160
Why?
Antigens, Neoplasm
4
2021
271
0.150
Why?
Time Factors
12
2020
7079
0.150
Why?
Hematopoietic Stem Cells
5
1996
432
0.150
Why?
Diphosphonates
1
2020
67
0.150
Why?
Diet
3
2018
1271
0.150
Why?
Pyrroles
2
2013
221
0.150
Why?
Bone Marrow
8
2000
308
0.150
Why?
Nuclear Medicine
1
2019
9
0.150
Why?
Hematology
1
2019
21
0.140
Why?
Bridged-Ring Compounds
4
2023
31
0.140
Why?
Cell Line, Tumor
9
2017
3538
0.140
Why?
MCF-7 Cells
5
2017
133
0.140
Why?
Proportional Hazards Models
6
2020
1318
0.140
Why?
CA-125 Antigen
2
2013
13
0.140
Why?
Fluorouracil
7
2013
231
0.140
Why?
Pyrazoles
2
2022
516
0.140
Why?
Epithelial-Mesenchymal Transition
1
2020
218
0.140
Why?
Pulmonary Medicine
1
2019
78
0.140
Why?
Thromboembolism
1
2019
129
0.140
Why?
Bayes Theorem
4
2024
424
0.130
Why?
Benzamides
5
2017
226
0.130
Why?
Research Design
3
2021
1139
0.130
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
59
0.130
Why?
Nitriles
5
2017
211
0.130
Why?
Tissue Inhibitor of Metalloproteinase-3
1
2017
9
0.130
Why?
Cyclin-Dependent Kinase 4
1
2018
52
0.130
Why?
Cell Cycle
1
2021
595
0.130
Why?
Cyclin-Dependent Kinase 6
1
2018
49
0.130
Why?
Infusions, Intravenous
10
2020
429
0.130
Why?
Kaplan-Meier Estimate
6
2018
959
0.130
Why?
Schwann Cells
1
2017
33
0.130
Why?
Tetrahydronaphthalenes
1
2017
34
0.130
Why?
Vaccines
1
2022
389
0.130
Why?
Sciatic Nerve
1
2017
63
0.130
Why?
Microbubbles
1
2017
51
0.130
Why?
Valine
1
2017
84
0.130
Why?
Betacoronavirus
1
2020
288
0.120
Why?
Societies, Medical
2
2019
901
0.120
Why?
Venous Thrombosis
1
2019
195
0.120
Why?
Amyloid Precursor Protein Secretases
1
2017
80
0.120
Why?
Lymph Node Excision
3
2015
173
0.120
Why?
Camptothecin
3
2024
139
0.120
Why?
Indoles
2
2013
509
0.120
Why?
Axilla
3
2017
51
0.120
Why?
Androgen Antagonists
2
2015
91
0.120
Why?
Cancer-Associated Fibroblasts
1
2016
23
0.120
Why?
Sulfonamides
1
2020
592
0.120
Why?
Gonadal Steroid Hormones
1
2018
143
0.120
Why?
Immunotherapy
2
2018
669
0.120
Why?
Hematopoietic Cell Growth Factors
2
1995
5
0.120
Why?
Neoplasms, Germ Cell and Embryonal
2
1995
76
0.120
Why?
Ultrasonography, Mammary
1
2016
17
0.120
Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
Why?
Lymphatic Metastasis
3
2017
335
0.120
Why?
Antibody Specificity
1
2016
181
0.120
Why?
Anesthesiology
1
2019
178
0.120
Why?
Internship and Residency
2
2024
1269
0.120
Why?
Tumor Suppressor Protein p53
2
2023
530
0.120
Why?
Thiazoles
1
2016
139
0.120
Why?
Neoplasm Invasiveness
3
2016
503
0.120
Why?
Follow-Up Studies
6
2025
5397
0.110
Why?
Myelin Sheath
1
2017
166
0.110
Why?
Maximum Tolerated Dose
1
2016
216
0.110
Why?
Neoplastic Stem Cells
2
2017
402
0.110
Why?
Antibiotics, Antineoplastic
1
2016
140
0.110
Why?
Benzimidazoles
1
2016
189
0.110
Why?
Ambulatory Care
1
2020
627
0.110
Why?
Quinolines
1
2016
191
0.110
Why?
Pneumonia, Viral
1
2020
387
0.110
Why?
Coronavirus Infections
1
2020
379
0.110
Why?
Drug Therapy, Combination
4
2014
1034
0.110
Why?
Recurrence
5
2020
1125
0.110
Why?
Mammography
1
2016
172
0.100
Why?
Animals
17
2021
38030
0.100
Why?
Radiotherapy, Adjuvant
5
2016
222
0.100
Why?
Disease Progression
7
2018
2857
0.100
Why?
Homeodomain Proteins
2
2018
525
0.100
Why?
Hepatic Veno-Occlusive Disease
3
2002
12
0.100
Why?
Brain Edema
1
2014
63
0.100
Why?
Administration, Oral
4
2020
867
0.100
Why?
Antibodies
1
2016
395
0.100
Why?
Radiotherapy Dosage
3
1999
289
0.100
Why?
Keratins
2
2017
57
0.100
Why?
TOR Serine-Threonine Kinases
1
2017
454
0.100
Why?
Young Adult
10
2025
14240
0.100
Why?
Testicular Neoplasms
1
1995
108
0.100
Why?
Vascular Neoplasms
1
2013
19
0.100
Why?
Clinical Trials, Phase I as Topic
3
2024
49
0.100
Why?
Comorbidity
5
2017
1652
0.100
Why?
Radiotherapy
3
2015
209
0.100
Why?
Apoptosis
6
2023
2436
0.100
Why?
Exercise
2
2015
2206
0.100
Why?
Epigenesis, Genetic
2
2018
705
0.100
Why?
Cellular Reprogramming
1
2014
98
0.100
Why?
Mercaptoethanol
2
1990
8
0.100
Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2022
137
0.100
Why?
Mice
12
2021
18266
0.090
Why?
Adenocarcinoma
6
2015
927
0.090
Why?
Cell Proliferation
6
2017
2497
0.090
Why?
Gallium Radioisotopes
1
1992
16
0.090
Why?
Patient Selection
4
2016
720
0.090
Why?
Bone Marrow Cells
4
2000
326
0.090
Why?
Protein-Tyrosine Kinases
2
2022
429
0.090
Why?
Carmustine
10
2001
52
0.090
Why?
Chromatin
1
2016
557
0.090
Why?
Adolescent
23
2025
22451
0.090
Why?
Anthracyclines
3
2023
49
0.090
Why?
Methotrexate
4
2002
234
0.090
Why?
Lymphoma, Non-Hodgkin
3
2001
124
0.090
Why?
Brain Neoplasms
5
2014
1324
0.080
Why?
Neoplasm, Residual
2
2022
143
0.080
Why?
Weight Reduction Programs
1
2012
140
0.080
Why?
Retrospective Studies
12
2023
17291
0.080
Why?
RNA, Catalytic
1
2012
191
0.080
Why?
Polydeoxyribonucleotides
2
2002
14
0.080
Why?
Age Factors
5
2019
3321
0.080
Why?
Risk Assessment
3
2020
3678
0.080
Why?
Multivariate Analysis
4
2013
1531
0.080
Why?
Neutropenia
5
2013
153
0.080
Why?
Neoplasm Grading
3
2017
313
0.080
Why?
Leukapheresis
4
2001
27
0.080
Why?
Aorta
1
2013
440
0.080
Why?
Carcinoma, Lobular
1
2011
59
0.080
Why?
Radiosurgery
1
2014
398
0.080
Why?
Keratin-5
1
2010
43
0.080
Why?
Biopsy
3
2018
1073
0.080
Why?
Angiogenesis Inhibitors
1
2012
238
0.080
Why?
Liver Neoplasms
3
2015
774
0.080
Why?
Peptide Mapping
1
2010
61
0.080
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
109
0.080
Why?
Molecular Targeted Therapy
3
2018
446
0.080
Why?
Piperazines
2
2023
367
0.080
Why?
Practice Patterns, Physicians'
1
2019
1370
0.070
Why?
Databases, Protein
1
2010
88
0.070
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2010
143
0.070
Why?
Urinary Tract
1
1990
47
0.070
Why?
Benzenesulfonates
1
2009
23
0.070
Why?
CD146 Antigen
2
2021
38
0.070
Why?
Postmenopause
2
2017
394
0.070
Why?
BRCA2 Protein
1
2009
68
0.070
Why?
Health Facilities
1
2009
85
0.070
Why?
Pregnancy Complications, Neoplastic
1
2009
64
0.070
Why?
Observer Variation
1
2010
355
0.070
Why?
Thrombophilia
1
2009
89
0.070
Why?
Patient Care
1
2009
120
0.070
Why?
Risk Factors
8
2020
10840
0.070
Why?
Mice, Nude
3
2017
665
0.070
Why?
Perimenopause
1
2008
69
0.070
Why?
United States
9
2023
16041
0.070
Why?
Fibrinolytic Agents
2
2002
302
0.060
Why?
In Situ Hybridization
2
2010
317
0.060
Why?
Bone Marrow Diseases
4
2000
20
0.060
Why?
In Situ Hybridization, Fluorescence
1
2008
333
0.060
Why?
Blotting, Western
1
2010
1176
0.060
Why?
Xenograft Model Antitumor Assays
3
2017
928
0.060
Why?
Fatigue
3
2018
362
0.060
Why?
Randomized Controlled Trials as Topic
6
2000
1754
0.060
Why?
Sputum
1
1988
302
0.060
Why?
Pneumonectomy
3
1997
167
0.060
Why?
Reproducibility of Results
2
2016
3396
0.060
Why?
Proto-Oncogene Proteins c-akt
2
2019
438
0.060
Why?
Quality of Life
2
2015
3187
0.060
Why?
Neoplasm Proteins
2
2007
443
0.060
Why?
Clinical Decision-Making
2
2020
364
0.050
Why?
Life Tables
2
2002
21
0.050
Why?
Anilides
2
2016
82
0.050
Why?
New Jersey
1
2024
17
0.050
Why?
Colony-Stimulating Factors
3
1988
37
0.050
Why?
Positron-Emission Tomography
1
2006
342
0.050
Why?
Enzyme Inhibitors
1
2008
820
0.050
Why?
Predictive Value of Tests
2
2016
2097
0.050
Why?
Receptor, TIE-2
1
2024
11
0.050
Why?
Oligonucleotide Array Sequence Analysis
3
2012
751
0.050
Why?
Granulocytes
4
1995
82
0.050
Why?
New York
1
2024
127
0.050
Why?
MicroRNAs
1
2010
695
0.050
Why?
Growth Substances
3
1988
136
0.050
Why?
Ricin
2
1997
8
0.050
Why?
Genes, Neoplasm
1
2004
26
0.050
Why?
Forecasting
3
2000
386
0.050
Why?
Thrombocytopenia
3
2013
205
0.050
Why?
Up-Regulation
2
2017
840
0.050
Why?
Patient Care Planning
1
2005
170
0.050
Why?
Anticoagulants
2
2019
743
0.050
Why?
Activating Transcription Factor 4
1
2023
22
0.050
Why?
Proteasome Inhibitors
1
2023
42
0.050
Why?
Signal Transduction
5
2018
5234
0.050
Why?
Magnetic Resonance Imaging
1
2016
3917
0.050
Why?
Proto-Oncogene Proteins c-mdm2
1
2023
66
0.050
Why?
G(M2) Ganglioside
1
2022
1
0.050
Why?
Injection Site Reaction
1
2022
4
0.050
Why?
Cyclin E
1
2022
23
0.050
Why?
Clinical Trials, Phase III as Topic
2
2000
116
0.050
Why?
Mammaplasty
2
2016
148
0.050
Why?
Proteomics
1
2010
1202
0.050
Why?
Treatment Failure
2
2001
358
0.050
Why?
Luminescent Measurements
1
2003
75
0.050
Why?
France
2
2019
40
0.050
Why?
Oncogene Proteins
1
2022
61
0.050
Why?
Ribose
1
2022
21
0.050
Why?
Blood Transfusion, Autologous
2
1993
18
0.050
Why?
Carbolines
1
2022
35
0.050
Why?
Heterocyclic Compounds, 4 or More Rings
1
2022
24
0.050
Why?
Proteasome Endopeptidase Complex
1
2023
155
0.050
Why?
Transcriptome
2
2023
1066
0.040
Why?
Adenosine Diphosphate
1
2022
75
0.040
Why?
Career Choice
1
2024
235
0.040
Why?
Imidazoles
1
2023
244
0.040
Why?
Pyrimidinones
1
2022
124
0.040
Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
109
0.040
Why?
Actuarial Analysis
2
1993
15
0.040
Why?
Oncogenes
1
2022
113
0.040
Why?
Cell Division
2
2001
735
0.040
Why?
Gene Expression
2
2020
1461
0.040
Why?
Colony-Forming Units Assay
4
1996
95
0.040
Why?
Tomography, X-Ray Computed
2
2015
2766
0.040
Why?
Carcinoembryonic Antigen
1
2001
40
0.040
Why?
Phthalazines
1
2021
63
0.040
Why?
Transplantation Immunology
1
2000
28
0.040
Why?
Clodronic Acid
1
2020
19
0.040
Why?
Progesterone
1
2002
214
0.040
Why?
Prospective Studies
5
2022
8087
0.040
Why?
Fellowships and Scholarships
1
2024
353
0.040
Why?
Ligands
1
2022
676
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2022
384
0.040
Why?
Longitudinal Studies
2
2012
3005
0.040
Why?
Estradiol
2
2016
517
0.040
Why?
Extracellular Matrix
1
2024
564
0.040
Why?
Topoisomerase I Inhibitors
1
1999
20
0.040
Why?
Thoracotomy
2
1997
87
0.040
Why?
Polymerase Chain Reaction
1
2003
1030
0.040
Why?
Leucovorin
2
1997
98
0.040
Why?
Hematopoietic Stem Cell Mobilization
1
1999
28
0.040
Why?
Bone Density Conservation Agents
1
2020
82
0.040
Why?
Mechlorethamine
1
2000
52
0.040
Why?
Dendritic Cells
2
2000
507
0.040
Why?
Neoplasms, Experimental
1
2000
163
0.040
Why?
Drug Resistance
1
1999
145
0.040
Why?
Receptors, Steroid
1
2019
41
0.040
Why?
Cluster Analysis
2
2012
494
0.040
Why?
Heterocyclic Compounds, 3-Ring
1
2019
44
0.040
Why?
Myelodysplastic Syndromes
1
2001
170
0.030
Why?
Etanidazole
1
1998
1
0.030
Why?
Child
8
2022
22638
0.030
Why?
Cell Cycle Proteins
1
2022
629
0.030
Why?
Enterocolitis, Pseudomembranous
1
1998
29
0.030
Why?
Leukemia
1
2001
246
0.030
Why?
Expectorants
1
1998
22
0.030
Why?
Aurora Kinase A
1
2018
57
0.030
Why?
Loss of Function Mutation
1
2018
47
0.030
Why?
Nervous System
2
1997
68
0.030
Why?
Disease Susceptibility
1
2020
339
0.030
Why?
Cross-Over Studies
1
2020
612
0.030
Why?
Statistics, Nonparametric
1
1999
423
0.030
Why?
Mediastinum
1
1998
23
0.030
Why?
Retreatment
1
2018
79
0.030
Why?
Nausea
1
2018
111
0.030
Why?
Epithelial Cell Adhesion Molecule
1
2017
10
0.030
Why?
Myelin Basic Protein
1
2017
44
0.030
Why?
ADAM17 Protein
1
2017
42
0.030
Why?
Administration, Intravenous
1
2018
172
0.030
Why?
Bromodeoxyuridine
1
2017
74
0.030
Why?
Extremities
2
1989
142
0.030
Why?
Breast
1
2018
154
0.030
Why?
SEER Program
1
2018
233
0.030
Why?
Watchful Waiting
1
2018
90
0.030
Why?
Diarrhea
1
2018
190
0.030
Why?
Cell Hypoxia
1
1998
247
0.030
Why?
Ganglia, Spinal
1
2017
88
0.030
Why?
Thorax
1
1997
51
0.030
Why?
Double-Blind Method
1
2022
2064
0.030
Why?
Coculture Techniques
1
2017
244
0.030
Why?
Random Allocation
2
1988
365
0.030
Why?
Phosphoramide Mustards
1
2016
3
0.030
Why?
Medicare
1
2023
907
0.030
Why?
Heterografts
1
2017
143
0.030
Why?
Immunotoxins
1
1997
51
0.030
Why?
Everolimus
1
2017
112
0.030
Why?
Cyclohexanes
1
2016
21
0.030
Why?
Cells, Cultured
2
2017
4112
0.030
Why?
Cell Survival
1
2000
1102
0.030
Why?
Cohort Studies
4
2001
6045
0.030
Why?
Cytochrome P-450 CYP3A
1
2017
93
0.030
Why?
Placebos
1
2016
190
0.030
Why?
Fluorescence Resonance Energy Transfer
1
2017
180
0.030
Why?
Gene Knockdown Techniques
1
2017
334
0.030
Why?
Ascorbic Acid
1
2017
183
0.030
Why?
Injections, Intravenous
2
1993
197
0.030
Why?
Carcinogenesis
1
2018
226
0.030
Why?
Antineoplastic Agents, Immunological
1
2018
200
0.030
Why?
Blood Specimen Collection
1
1995
37
0.030
Why?
Fertility Preservation
1
2016
57
0.030
Why?
Organoplatinum Compounds
3
1990
65
0.030
Why?
Antidotes
1
1997
145
0.030
Why?
Lymphoma, Large B-Cell, Diffuse
1
1998
195
0.030
Why?
Digestive System
1
1995
29
0.030
Why?
Transcriptional Activation
1
2017
368
0.030
Why?
Genetic Therapy
1
1997
303
0.030
Why?
Blood Component Transfusion
2
1994
99
0.030
Why?
Mortality
1
1997
375
0.030
Why?
Animals, Newborn
1
2017
887
0.030
Why?
Vincristine
1
1995
148
0.030
Why?
Hormones
1
2015
134
0.030
Why?
Interleukin-3
1
1994
23
0.030
Why?
Fertility
1
2016
173
0.030
Why?
Kidney
2
1995
1491
0.030
Why?
Diagnosis, Differential
1
2019
1500
0.030
Why?
Weight Gain
1
2018
561
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
266
0.030
Why?
Pulmonary Fibrosis
3
1993
395
0.030
Why?
Leukocyte Count
5
1996
319
0.030
Why?
Bacterial Infections
1
1996
246
0.030
Why?
Odds Ratio
1
2017
1070
0.030
Why?
Tosyl Compounds
1
2014
17
0.030
Why?
Antioxidants
1
2017
544
0.030
Why?
Drug Discovery
1
2015
153
0.030
Why?
Adipose Tissue
1
2018
641
0.030
Why?
Child, Preschool
6
2013
11888
0.020
Why?
Hand-Foot Syndrome
1
2013
2
0.020
Why?
Protein Transport
1
2015
439
0.020
Why?
HEK293 Cells
1
2016
746
0.020
Why?
Transplantation, Heterologous
1
2014
165
0.020
Why?
Capecitabine
1
2013
56
0.020
Why?
Neoplasm Transplantation
1
2014
238
0.020
Why?
Necrosis
1
2014
243
0.020
Why?
Erythropoietin
1
1994
100
0.020
Why?
Gene Silencing
1
2014
200
0.020
Why?
Binding Sites
1
2016
1306
0.020
Why?
Cell Nucleus
1
2016
584
0.020
Why?
Alternative Splicing
1
2015
249
0.020
Why?
Blood Cells
1
1993
38
0.020
Why?
Nutritional Status
1
2015
344
0.020
Why?
Recombinant Proteins
5
1997
1361
0.020
Why?
CD24 Antigen
1
2012
18
0.020
Why?
Cross-Sectional Studies
1
2024
5875
0.020
Why?
Sensitivity and Specificity
2
2000
1992
0.020
Why?
Anemia
1
1994
189
0.020
Why?
Energy Intake
1
2015
506
0.020
Why?
Diet, Reducing
1
2012
90
0.020
Why?
Radionuclide Imaging
1
1992
116
0.020
Why?
Models, Biological
1
1999
1758
0.020
Why?
Antigens, CD34
3
1996
89
0.020
Why?
Psychotherapy, Group
1
2012
79
0.020
Why?
Hyaluronan Receptors
1
2012
105
0.020
Why?
Counseling
1
2015
403
0.020
Why?
Emergency Medical Services
1
2019
680
0.020
Why?
Mice, SCID
1
2012
360
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
74
0.020
Why?
Surveys and Questionnaires
1
2024
6050
0.020
Why?
Pandemics
1
2020
1700
0.020
Why?
Tumor Burden
1
2012
326
0.020
Why?
Fluorescent Antibody Technique
2
1990
345
0.020
Why?
Feasibility Studies
4
1998
1125
0.020
Why?
Logistic Models
1
2016
2112
0.020
Why?
Biopsy, Needle
1
2011
182
0.020
Why?
Mice, Inbred NOD
1
2012
598
0.020
Why?
Chromosomes, Human, Pair 9
1
1990
36
0.020
Why?
Blast Crisis
1
1990
34
0.020
Why?
Immunoblotting
1
2010
294
0.020
Why?
Chromosomes, Human, Pair 22
1
1990
46
0.020
Why?
Colorado
1
2020
4588
0.020
Why?
Disease Models, Animal
1
2021
4565
0.020
Why?
Bilirubin
2
2002
101
0.020
Why?
Graft Survival
1
1993
508
0.020
Why?
Pemetrexed
1
2010
40
0.020
Why?
Cytokines
1
1998
2079
0.020
Why?
Glutamates
1
2010
66
0.020
Why?
Health Status
1
2015
822
0.020
Why?
Antibodies, Anti-Idiotypic
1
1990
50
0.020
Why?
Magnetics
1
1990
45
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2010
333
0.020
Why?
Guanine
1
2010
85
0.020
Why?
Multiple Organ Failure
2
2002
122
0.020
Why?
Urologic Diseases
1
1990
42
0.020
Why?
Gene Regulatory Networks
1
2012
319
0.020
Why?
Kidney Diseases
2
1991
427
0.020
Why?
Hypertension
1
2018
1270
0.020
Why?
Microspheres
1
1990
142
0.020
Why?
Health Behavior
1
2015
801
0.020
Why?
Chromosome Aberrations
1
1990
167
0.020
Why?
Spinal Cord Neoplasms
1
1989
40
0.020
Why?
Blood
1
1990
107
0.020
Why?
RNA, Messenger
1
2017
2783
0.020
Why?
Cell Movement
1
2014
950
0.020
Why?
Clone Cells
1
1990
259
0.020
Why?
Promoter Regions, Genetic
1
2014
1236
0.020
Why?
Pregnancy Trimester, Second
1
2009
91
0.020
Why?
Central Nervous System Diseases
1
1990
73
0.020
Why?
Hematuria
1
1989
11
0.020
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1990
128
0.020
Why?
Vinblastine
2
2001
75
0.020
Why?
Rats
1
2017
5574
0.020
Why?
Creatinine
1
1991
511
0.020
Why?
False Negative Reactions
1
1988
61
0.020
Why?
Pregnancy Trimester, First
1
2009
139
0.020
Why?
Immunophenotyping
2
2000
324
0.020
Why?
DNA Methylation
1
2014
721
0.020
Why?
Leukopenia
1
1988
33
0.020
Why?
Lymphoma
1
1990
251
0.020
Why?
Apoptosis Regulatory Proteins
1
2009
186
0.020
Why?
Hospitals, Veterans
1
2009
256
0.020
Why?
False Positive Reactions
1
1988
124
0.020
Why?
Histones
1
2014
670
0.020
Why?
Drug Interactions
1
1990
403
0.020
Why?
Electrophoresis
1
1988
31
0.020
Why?
Antigens, Differentiation
1
1988
75
0.020
Why?
Transfection
1
2010
914
0.020
Why?
Phenylurea Compounds
1
2009
122
0.020
Why?
Estrogen Receptor Modulators
1
2008
14
0.020
Why?
Perilipin-1
1
2008
16
0.020
Why?
Niacinamide
1
2009
103
0.020
Why?
Neurons
1
2017
1663
0.020
Why?
Gene Expression Regulation
1
2017
2591
0.020
Why?
S100 Proteins
1
2008
33
0.020
Why?
Staining and Labeling
1
1988
148
0.020
Why?
Antigens, Surface
1
1988
155
0.020
Why?
Macrophages
2
1995
1530
0.020
Why?
Vimentin
1
1988
47
0.020
Why?
Androstadienes
1
2008
77
0.020
Why?
Community Health Services
1
2009
229
0.020
Why?
Exercise Therapy
1
2012
486
0.020
Why?
Nervous System Diseases
1
1991
286
0.020
Why?
Central Nervous System
1
1990
278
0.020
Why?
Sarcoma, Kaposi
1
1988
82
0.020
Why?
Genetic Predisposition to Disease
1
2016
2455
0.020
Why?
Bone Marrow Purging
2
1996
3
0.020
Why?
Clinical Trials, Phase II as Topic
2
2000
74
0.020
Why?
Lung Diseases
2
1992
787
0.020
Why?
Biomarkers
1
2018
4329
0.020
Why?
Heart Diseases
1
1990
341
0.020
Why?
Health Knowledge, Attitudes, Practice
1
2015
1403
0.020
Why?
Risk
2
2000
917
0.010
Why?
Academic Medical Centers
1
2009
560
0.010
Why?
Phosphoproteins
1
2008
319
0.010
Why?
Stem Cell Transplantation
1
2007
189
0.010
Why?
Gastrointestinal Diseases
1
2008
220
0.010
Why?
Immunoglobulin G
1
1990
899
0.010
Why?
Bevacizumab
1
2006
167
0.010
Why?
Quality of Health Care
1
2009
692
0.010
Why?
Melanoma
2
1988
764
0.010
Why?
Body Mass Index
1
2012
2446
0.010
Why?
Carrier Proteins
1
2008
728
0.010
Why?
Ascites
1
2002
47
0.010
Why?
Phenotype
1
2010
3186
0.010
Why?
Brain
1
2014
2981
0.010
Why?
Carcinoma, Lewis Lung
1
2001
16
0.010
Why?
Carcinoma, Large Cell
1
2001
17
0.010
Why?
Transplantation Conditioning
1
2002
191
0.010
Why?
Phytohemagglutinins
1
2000
29
0.010
Why?
CD4-CD8 Ratio
1
2000
23
0.010
Why?
Lymphocyte Culture Test, Mixed
1
2000
49
0.010
Why?
Hypersensitivity, Delayed
1
2000
30
0.010
Why?
Drug Synergism
1
2001
353
0.010
Why?
Skin Tests
1
2000
94
0.010
Why?
Microcomputers
1
2000
17
0.010
Why?
Hemorrhage
2
1998
824
0.010
Why?
Louisiana
1
2000
30
0.010
Why?
Philadelphia
1
2000
55
0.010
Why?
Immunoglobulins
1
2000
162
0.010
Why?
Graft vs Host Disease
1
2002
280
0.010
Why?
Automation
1
2000
104
0.010
Why?
Immunity
1
2000
140
0.010
Why?
Lipopolysaccharide Receptors
1
1999
88
0.010
Why?
Marriage
1
1980
122
0.010
Why?
Lung
1
1992
4119
0.010
Why?
Personnel Selection
1
1980
90
0.010
Why?
Interleukin-4
1
1999
207
0.010
Why?
Thalassemia
1
1998
6
0.010
Why?
Receptors, Purinergic P1
1
1998
30
0.010
Why?
Heart Failure
1
1992
2323
0.010
Why?
Microscopy, Fluorescence
1
2000
403
0.010
Why?
Reference Values
1
2000
787
0.010
Why?
Multicenter Studies as Topic
1
2000
413
0.010
Why?
Acute Disease
1
2001
1033
0.010
Why?
Pilot Projects
2
1994
1878
0.010
Why?
Infant, Newborn
1
2009
6449
0.010
Why?
Filgrastim
1
1997
13
0.010
Why?
Adenoviruses, Human
1
1996
26
0.010
Why?
Heparin
1
1998
246
0.010
Why?
Killer Cells, Natural
1
2000
481
0.010
Why?
Tissue Plasminogen Activator
1
1998
244
0.010
Why?
Freezing
1
1996
84
0.010
Why?
Lymphocyte Activation
1
2000
1136
0.010
Why?
Pregnancy
1
2009
7217
0.010
Why?
Lymphoma, B-Cell
1
1998
149
0.010
Why?
Lymphocyte Depletion
1
1996
135
0.010
Why?
Genes, Reporter
1
1996
273
0.010
Why?
Carcinoma, Squamous Cell
1
2001
627
0.010
Why?
Drug Tolerance
1
1995
99
0.010
Why?
Reticulocyte Count
1
1994
7
0.010
Why?
Kidney Function Tests
1
1995
154
0.010
Why?
Topotecan
1
1994
17
0.010
Why?
Incidence
1
2001
2910
0.010
Why?
Liver
1
2002
1859
0.010
Why?
Antigens, CD
1
1996
559
0.010
Why?
Urinary Bladder Diseases
1
1993
18
0.010
Why?
Glioblastoma
1
1996
349
0.010
Why?
Heart
1
1997
624
0.010
Why?
Boston
1
1993
90
0.010
Why?
Registries
1
2002
2382
0.010
Why?
Flow Cytometry
1
1996
1160
0.010
Why?
Chromatography, High Pressure Liquid
1
1995
588
0.010
Why?
Iron
1
1994
359
0.010
Why?
Cell Line
1
1996
2809
0.010
Why?
Immunologic Factors
1
1993
244
0.000
Why?
Cystitis
1
1990
24
0.000
Why?
Palliative Care
1
1998
1032
0.000
Why?
Prostatic Neoplasms
1
1996
972
0.000
Why?
Metabolic Clearance Rate
1
1989
115
0.000
Why?
Introns
1
1990
257
0.000
Why?
Platinum
1
1989
48
0.000
Why?
Macrophage-1 Antigen
1
1988
26
0.000
Why?
Brain Diseases
1
1990
157
0.000
Why?
Bone Marrow Examination
1
1988
5
0.000
Why?
Drug Combinations
1
1990
399
0.000
Why?
Erythrocyte Count
1
1988
20
0.000
Why?
Platelet Count
1
1988
94
0.000
Why?
Methods
1
1988
68
0.000
Why?
Pelvic Neoplasms
1
1988
24
0.000
Why?
Erythroblasts
1
1988
18
0.000
Why?
Infant
1
2002
10093
0.000
Why?
DNA Damage
1
1990
437
0.000
Why?
Acute Kidney Injury
1
1995
861
0.000
Why?
In Vitro Techniques
1
1988
1041
0.000
Why?
Fever
1
1988
320
0.000
Why?
Pneumonia
1
1992
633
0.000
Why?
Statistics as Topic
1
1987
277
0.000
Why?
Elias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)